Business Description
BioLASCO Taiwan Co Ltd
ISIN : TW0006662000
Total Employee Number:
90Description
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kits and equipment which include Allentown, a Biomedical data system, and PLAS LABS.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.43 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | 1.39 | |||||
Interest Coverage | 24.31 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.78 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.6 | |||||
3-Year EBITDA Growth Rate | -0.6 | |||||
3-Year FCF Growth Rate | -12.6 | |||||
3-Year Book Growth Rate | 0.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.02 | |||||
9-Day RSI | 50.71 | |||||
14-Day RSI | 51.37 | |||||
3-1 Month Momentum % | 1.54 | |||||
6-1 Month Momentum % | -0.67 | |||||
12-1 Month Momentum % | -12.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.33 | |||||
Quick Ratio | 2.03 | |||||
Cash Ratio | 1.46 | |||||
Days Inventory | 61.5 | |||||
Days Sales Outstanding | 55.67 | |||||
Days Payable | 15.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.97 | |||||
Dividend Payout Ratio | 0.89 | |||||
3-Year Dividend Growth Rate | -2.1 | |||||
Forward Dividend Yield % | 5.13 | |||||
5-Year Yield-on-Cost % | 3.86 | |||||
Shareholder Yield % | 6.6 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.2 | |||||
Operating Margin % | 18.74 | |||||
Net Margin % | 16.45 | |||||
EBITDA Margin % | 24.63 | |||||
FCF Margin % | 12.03 | |||||
OCF Margin % | 20.59 | |||||
ROE % | 10 | |||||
ROA % | 7.29 | |||||
ROIC % | 10.36 | |||||
3-Year ROIIC % | 1.58 | |||||
ROC (Joel Greenblatt) % | 20.17 | |||||
ROCE % | 10.17 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.87 | |||||
PE Ratio without NRI | 17.87 | |||||
Shiller PE Ratio | 12.63 | |||||
Price-to-Owner-Earnings | 15.75 | |||||
PS Ratio | 2.93 | |||||
PB Ratio | 1.85 | |||||
Price-to-Tangible-Book | 1.84 | |||||
Price-to-Free-Cash-Flow | 24.39 | |||||
Price-to-Operating-Cash-Flow | 14.27 | |||||
EV-to-EBIT | 13.89 | |||||
EV-to-EBITDA | 11.31 | |||||
EV-to-Revenue | 2.78 | |||||
EV-to-FCF | 22.95 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 1.5 | |||||
Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 19.36 | |||||
Earnings Yield (Greenblatt) % | 7.2 | |||||
FCF Yield % | 4.11 | |||||
Forward Rate of Return (Yacktman) % | 2.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioLASCO Taiwan Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 263.807 | ||
| EPS (TTM) (NT$) | 1.69 | ||
| Beta | 0.0171 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.46 | ||
| Volatility % | 16.41 | ||
| 14-Day RSI | 51.37 | ||
| 14-Day ATR (NT$) | 0.722528 | ||
| 20-Day SMA (NT$) | 30.13 | ||
| 12-1 Month Momentum % | -12.28 | ||
| 52-Week Range (NT$) | 28 - 34.5 | ||
| Shares Outstanding (Mil) | 25.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioLASCO Taiwan Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioLASCO Taiwan Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.550000 Cash Dividend | 2026-08-07 | 29.95 (+0.84%) | ||
| TWD 1.500000 Cash Dividend | 2025-08-07 | 33.80 (-0.29%) | ||
| 1.055:1 Stock Split | 2018-07-30 | 47.87 (+0.00%) |
Show
Entries
BioLASCO Taiwan Co Ltd Frequently Asked Questions
What is BioLASCO Taiwan Co Ltd(ROCO:6662)'s stock price today?
The current price of ROCO:6662 is NT$30.20. The 52 week high of ROCO:6662 is NT$34.50 and 52 week low is NT$28.00.
When is next earnings date of BioLASCO Taiwan Co Ltd(ROCO:6662)?
The next earnings date of BioLASCO Taiwan Co Ltd(ROCO:6662) is .
Does BioLASCO Taiwan Co Ltd(ROCO:6662) pay dividends? If so, how much?
The Dividend Yield %  of BioLASCO Taiwan Co Ltd(ROCO:6662) is 4.97% (As of Today), Highest Dividend Payout Ratio of BioLASCO Taiwan Co Ltd(ROCO:6662) was 1.14. The lowest was 0.77. And the median was 0.88. The  Forward Dividend Yield % of BioLASCO Taiwan Co Ltd(ROCO:6662) is 5.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BioLASCO Taiwan Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers